Related Experiment Videos
Sentinel lymphadenectomy in node negative breast cancer
1Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA, USA.
Cancer Treatment and Research
|August 19, 2000
Summary
Sentinel lymph node dissection (SLND) accurately predicts axillary lymph node status in breast cancer, supporting the sentinel node hypothesis. This minimally invasive procedure offers precise staging with low morbidity for patients.
Area of Science:
- Oncology
- Surgical Pathology
- Nuclear Medicine
Background:
- Accurate staging of axillary lymph nodes is critical in breast cancer management.
- Sentinel lymph node dissection (SLND) is a minimally invasive technique to identify metastatic spread.
- The sentinel node hypothesis posits that the first lymph node(s) draining a tumor are most likely to contain metastases.
Purpose of the Study:
- To evaluate the precision of SLND in predicting axillary lymph node status in breast cancer.
- To assess the feasibility and morbidity associated with SLND.
- To support the sentinel node hypothesis in the context of breast cancer staging.
Main Methods:
- SLND performed using various techniques.
- Pathological analysis of sentinel lymph nodes.
- Comparison of SLND results with axillary lymph node dissection (ALND) for validation.
Main Results:
- SLND accurately predicts axillary lymph node status, irrespective of the method used.
- The procedure is well-tolerated, achieving accurate staging with minimal morbidity.
- A negative sentinel node reliably indicates node-negative status in most cases when performed by experienced surgeons.
Conclusions:
- SLND is a highly accurate and minimally invasive method for staging breast cancer patients.
- Consistent results across different techniques validate the sentinel node hypothesis.
- Further multicenter trials are needed to fully define the role of SLND alone versus ALND in early breast cancer management.